Table 4.
Analysis of the gut microbiota.
| Taxon Name | Taxonomic Relative Abundance | |||||
|---|---|---|---|---|---|---|
| −KES | +KES | |||||
| Before | After | p-Value | Before | After | p-Value | |
| Escherichia coli group | 3.74 ± 10.08 | 4.28 ± 5.98 | 0.799 | 3.78 ± 9.33 | 1.76 ± 4.08 | 0.023 |
| Blautia wexlerae | 3.08 ± 3.94 | 3.45 ± 3.68 | 0.832 | 2.87 ± 2.20 | 2.67 ± 2.73 | 0.523 |
| Streptococcus salivarius group | 3.13 ± 5.95 | 3.97 ± 6.55 | 0.417 | 3.92 ± 6.40 | 5.03 ± 5.03 | 0.368 |
| Bifidobacterium adolescentis group | 1.62 ± 3.26 | 3.02 ± 9.79 | 0.570 | 0.80 ± 2.44 | 1.53 ± 4.27 | 0.722 |
| Enterococcus faecium group | 0.02 ± 0.03 | 0.85 ± 3.10 | 0.079 | 4.83 ± 20.39 | 4.10 ± 12.90 | 0.540 |
−KES, the group that did not receive 1-kestose; +KES, the group that was administered 1-kestose. Comparison of the microbiome in feces from baseline to week 12 in −KES and +KES group using the Wilcoxon test.